December 27th, 2007
SGX393: New Drug Candidate That Knocks Out Resistant Form of Chronic Myeloid Leukemia (CML)
A new experimental drug has been found by Oregon Health & Science University (OHSU) Cancer Institute researchers to be effective against a highly resistant mutation in chronic myeloid leukemia (CML).
The said new drug candidate - SGX393 - has been found to inhibit most resistant mutations — including T315I — both in mouse models and […]
Recent Comments